Actively Recruiting
Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
Led by University Hospital, Basel, Switzerland · Updated on 2025-02-13
50
Participants Needed
3
Research Sites
865 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Basel, Switzerland
Lead Sponsor
U
University of the Italian Switzerland
Collaborating Sponsor
AI-Summary
What this Trial Is About
Intravitreal dyes are intended to make the surgical extraction of the Internal limiting membrane (ILM) safer and more complete. However, the search for an adequate vitaly dye is ongoing. The most commonly used vital dye is Indocyanine green (ICG), although it is not approved for intravitreal use and has been associated with ocular toxicity. The reason for its continued popularity seems to be that it stains the ILM better than the approved and less toxic alternative substances Brilliant Blue G (BBG) and Trypan blue (TB). According to anecdotal reports from surgeons, another reason for ICGs popularity may be the fact that it seems to make ILM removal easier. Ultimately, the intention of the investigators research is to identify possible modifications to existing dyes to reach improved intraoperative dye utility combined with a favorable safety profile. Protocol was amended and approved concerning additional use of basal membrane of deceased donors.
CONDITIONS
Official Title
Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 Years of age
- No other chromovitrectomy in previous 6 months
- Only one of three vitaly dyes used intraoperatively (BBG, ICG or TB)
You will not qualify if you...
- Previous chromovitrectomy during last 6 months
- Pregnant patients
- Patients under 18 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
General Hospital Linz
Linz, Austria, 4010
Actively Recruiting
2
St. Gallen Hospital
Sankt Gallen, Canton of St. Gallen, Switzerland, 9007
Actively Recruiting
3
Oftacentro
Paradiso, Canton Ticino, Switzerland, 6900
Actively Recruiting
Research Team
P
Paul B. Henrich, MD, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here